CHINEDU IBEMADU: Open Payments
NPI 1679270979 · DARIEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 9 payments from 6 companies in 2025. Trend: 2023 $287 · 2024 $330 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $175 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Indivior Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: INGREZZA, Auvelity, SUBLOCADE, UZEDY, ARISTADA, REXULTI.
Industry payments across CT — which companies pay providers there.
